Jack Borrok is a seasoned professional in the field of biochemistry and protein engineering. Currently serving as Director at Amgen since October 2023, Jack previously held the position of Director of Protein Engineering at Horizon from October 2021 to October 2023. Prior experience includes serving as Principal Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson from September 2019 to October 2021 and as a Scientist at MedImmune from August 2010 to September 2019. Jack also held the role of Scientist II at AstraZeneca during the same period and worked as a Post Doctoral Researcher at the University of Texas at Austin from 2007 to 2010. Educational qualifications include a Post Doc in Protein Engineering from The University of Texas at Austin, a Ph.D. in Biochemistry from the University of Wisconsin-Madison, and a B.S. in Biochemistry from the University of Missouri-Columbia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices